
--- Page 1 ---
UUID: B660432A-A67B-40CC-89F8-80648DB8AE980 TCGA-C8-A26Y-01A-PR Redacted IRB APPROVED MultI-media systems, Inc. Form Revised Clinical Case Report. 1cs-0-3 (For Collection of Cancerous Tissue) Cauiona, nifiltnahng cluct, nos 8500f3 Sife: breaot, Nos c50.9 lw 5/3sf Informed Consent I personally informed this patient that a specimen(s) would be collected to be used for research purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Name of Physician or Study Coordinator Signature Date Clinical Information. AAOOSGENERALINFORMATION . Date of Birth (mm/dd/yyyy) Height Marital Status  Race Temperature.  Single Married Gender Weight  Divorced  Widow Blood Pressure Heart Rate 1218  Male XDFemale OOASNRHISTORYOEPRESENTILLNESS Symptoms: Clinical Findings:s A tumeur was found the Leff hreag Performance Scale (Karnofsky Score):  100 Asymptomatic   80-90 Symptomatic but Fully Ambulatory   60-70 Symptomatic, in bed less than 50% of day. Xj40-50 Symptomatic, in bed more than 50% of day, but not bed ridden     20-30 Bed Ridden AEONCURRENTMEDICATIONSs Drug Dose Route Frequency Date (mm/dd/yyyy) To 1 To / To To To

--- Page 2 ---
PAST MEDICAL HISTORY Diagnosis Date Treatment Status Diagnosis/Disease/Disorder/Injury POBGYNHISTORY # of Pregnancies Date of First Menses  Menopausal Status 0 5  Pre-menopausal # of Live Births  Peri-Menopausal Date of Last Menses jAPost-menopausal Don'+ Mromhe  IUD  Hormone Replacement   Oral Contraceptive Birth Control:  Condom Therapy:  Other: LOSOCALHISTORYT Environmental Hazards: Occupation: Smoking History Duration When Quit TYPE Packs/day Current Status (yrs) () O YES y0NO Alcohol Consumption Duration When Quit TYPE Drinks/day Current Status (yrs) (yr  yeS PNO Drug Use Duration When Quit Frequency TYPE Current Status (yrs) (yr  YES NO ETFAMILYMEDICAEHISTORYAAAW Age of Diagnosis Diagnosis Relative LABDATAW Date Test  Result Date Result Test CEA   Negative  Positive: HIV Negative  Positive:  Negative  Positive: i/ CA 15-3  Negative  Positive: Hep B CA 19-9   Negative  Positive: Hep C Negative  Positive:   Negative  Positive: PSA AFP  Negative  Positive: Other:  Negative  Positive: Other:  Negative  Positive: B/T Cell Markers: 2

--- Page 3 ---
Study Results Ultrasound X-Ray Date CT Endoscopy MRI Biopsy Boewst Casses Preoperative Clinical Diagnosis  Location of Suspected Involved Lymph Nodes Location of Suspected Distant Metastasis Clinical Staging T2 NO M o Date of Diagnosis Stage: -- Treatment Information Procedure Mgi?eo! Padica. Masteetmoss Date of Procedure Primary Tumor Organ Left bseast tumuR Detailed Location u0peR crToR Fuad(kayL3 x2 x 2 cm Size Extension of Tumor Lymph Nodes Description  Palpable, Non-Dissected Lymph Nodes Location of Lymph Nodes # of Lymph Nodes Dissected Lymph Nodes Distant Metastasis Organ Detailed Location Size  Surgical Staging T 2 No.. M Q. Stage: NEOADJUVENTTHERAPY (Chemo, Radiation Immuno Hormonalor Molecular) Drug/Treatment Dose Route Frequency Date (mm/dd/yyyy) To 1 To 1 To / To To

--- Page 4 ---
Pathology Form Specimen Information Collected by: Dat Preserved by: Dat SPECIMENTYPE(#ofSamplesprOvided). Frozen  Paraffin Block Blood/Serum/Plasma Slide Diseased  Normal Diseased  Normal Diseased Normal Diseased  Normal 3 3 2 3 2 2 Time to LN2 Time to Formalin Time to LN2 72 min min  min DMAAXTOPATHOLOGICAEDESCRIPTIONMASMNTSA Primary Tumor Organ Size Extension of Tumord Distance to NAT 3 x 2 x 2 cm|ecms erTee 6 eet haeast timen cm Lymph Nodes # Examined # Metastasized Location Distant Metastasis  Organ Detailed Location. Size Pathological Staging No m O Stage: I pT 2 Notes: BRexgFrodl li riitrage ( M, H2 )

--- Page 5 ---
Microscopic Description Cell Distribution Structural Pattern Diffuse p +  Streaming Mosaic Storiform Necrosis Fibrosis Lymphocytic Infiltration  Palisading Vascular Invasion Cystic Degeneration Clusterized Bleeding  Alveolar Formation Myxoid Change Indian File  Psammoma/Calcification CellularDifferentiton Squamous +-  Adenomatous +  Sarcomatous  Squamoid Cell Lymphomatous Glandular cell + Round Ceil Spindle Cell Cell Stratification Large Cell Fibroblast  Keratin  Secretion Small Cell Osteoblast RS Cell/RS Like Desmosome Intracyt. Vacuole  Lipoblast Pear! Inflam. Cell Gland formation x  Myoblast Plasma Cell Cellular Differentiation: Well Moderate  www NuclearAppearanceww*+*  Poor Nuclear Atypia: 0 1  Aniso Nucleosis II III Hyperchromatism Nucleolar Prominent Multinucleated Giant Cell Mitotic Activity Nuclear Grade: Marker Result Value Date ER  Negative  Positive PR  Negative  Positive  Her-2/neu  Negative  Positive B-Cell Marker  Negative  Positive T-Cell Marker  Negative   Positive Other:  Negative  Positive Other:  Negative   Positive Final Pathology Report : Tpsil toe li g. oluc Tal cagceaem? Histological Diagnosis: f pssghe tale h. dieRastialed Grade:7 Comments: (M,,M2 nfeGx Ty'ceJ Principal invesuga. Pathologist Date 5

--- Page 6 ---
COnsOLIdated DIagnOstIc patholOgy fOrm* Microscopic Appearance: . Histological pattern: CELL DISTRIBUTION Diffuse STRUCTURAL PATTERN Mosaic x Streaming Necrosis  Storiform Lymphocytic Infiltration Fibrosis Vascular Invasion Palisading Chusterized Cystic Degeneration  Alveoiar Formation Bieeding Indian File 2. Cellular features:  Psammoma/Calcification Squamows Adenomatous Squamoid Cell + I Sarcomatous Glandular cel! +1 Lymphomatous Spindle Cell Round Cel! Cell Stratification + Large Cell Keratin Fibroblast Secretion Small Cetl Desmosome x Osteoblast Intracyt. Vacuole RS CelVRS Like  Lipoblast Peart  Gland formation Inflam. Cell KMyobiast Other wise Specified: Plasma Cell D1 5o% t Dr 9OZe Dz40 een s 2.Cellular Differentlation: Well Moderatcly Poor N Nuclear Atypia: Nuciear Appcarance Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinscleated Giant Cel! x Mitotic Activity Nuckear Grade Histological Diagnosis: Tnhltossss. Auetal lagei? ore Vot, :Clesns.. Lnorsh gceuss Comments:... Date PATHOLOGIST STAFF FOR RESEARCH USE ONLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR ANDS